We examined the effect of interleukin-3 (IL-3) on human CD4+ cloned T cells, P607 and 1C2. By flow cytometric analysis, we found that IL-3 downregulated the surface expression of IL-2 receptor (R) $ chain in a dose-dependent manner but had little effect on that of IL-2R Q chain. A simultaneous lallabeled IL-2 binding assay showed a decrease in the number of high-affinity, but not of low-affinity, IL-2Rs by IL-3. The downregulation of the IL-2R $ chain began 3 hours after culture initiation, increased further thereafter, and was completely inhibited by anti-IL-3 antibodies. Expression of mRNA for either Q or $ chain was not reduced by IL-3, and this NTERLEUKIN-2 (IL-2) plays an essential role in T-lym-I phocyte (T-cell) activation and subsequent proliferation, exerting its effect through specific receptors expressed on the T cells. The IL-2 receptor (IL-2R) consists of at least two subunits, p55 (Tac, a chain) and p75 (p chain), and the affinity of IL-2 to its receptors is defined by each chain involved in IL-2 binding. When each IL-2R subunit is present alone, low (dissociation constant [kd] 10 nmol/L) and intermediate (kd 1 nmol/L) affinity of IL-2R is expressed, and they make a high-affinity IL-2R complex (kd 10 pmol/L) when combined. The a chain alone cannot transduce the IL-2-mediated signal, but the p chain plays a key role in transmitting an IL-2 signal.
I phocyte (T-cell) activation and subsequent proliferation, exerting its effect through specific receptors expressed on the T cells. The IL-2 receptor (IL-2R) consists of at least two subunits, p55 (Tac, a chain) and p75 (p chain), and the affinity of IL-2 to its receptors is defined by each chain involved in IL-2 binding. When each IL-2R subunit is present alone, low (dissociation constant [kd] 10 nmol/L) and intermediate (kd 1 nmol/L) affinity of IL-2R is expressed, and they make a high-affinity IL-2R complex (kd 10 pmol/L) when combined. The a chain alone cannot transduce the IL-2-mediated signal, but the p chain plays a key role in transmitting an IL-2 signal.
There have been many reports about the effects of various factors on IL-2R expression. IL-2 upregulates the expression of a chain on T c e W 4 by increasing the gene transcription rate. Also producing similar effects are IL-1 (T cells5x6 and natural killer cells'), IL-5 (B cells*), IL-7 (T cells9~"'), adult T-cell leukemia-derived factor,"." tumor necrosis fa~tor-a,'~ and pr~lactin.'~ However, few data are available on those factors that regulate the expression of p chain. The concept that IL-4 downregulates expression of IL-2 receptor p is IL-3 was initially defined as the factor in conditioned media from concanavalin A-stimulated splenic lymphocytes that promotes induction of 20-a-hydroxysteroid dehydrogenase in nu/nu splenic lymphocytes.'' Subsequently, it has been shown to have multiple functions, to affect various cell types, and to be identical to previously reported factors'' including mast cell growth factor, P-cell-stimulating factor, histamine-producing cell-stimulating factor, burst-promoting activity factor, and multipotent hematopoietic progenitor cell growth factor acting on the early stage of development. There have been reports that IL-3 supports the continuous growth of murine helper T cells2' and promotes the IL-2-driven growth of human T cells,22 but further studies are needed to define its exact function in these cells. In the present study, we examine the effect of IL-3 on human T cells and find that IL-3 modulates the IL-2-mediated cell growth by downregulating the surface expression of the IL-2R p chain but not that of the a chain.
MATERIALS AND METHODS
We separated peripheral blood mononuclear cells (PBMCs) from heparinized venous blood of healthy volunteers by FicolliHypaque (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) gradient centrifugation and cultured them for 2 to 8 weeks in medium containing 1 nmol/L recombinant IL-2 (1 U/mL = 0.5 nmol1L; kindly provided by Takeda Chemical Industries, Osaka, Japan) with repeated stimulations with 0.1% phytohemagglutinin-P (PHA-P; Difco, Detroit, MI). The cells were then cloned by limiting dilution procedures. We seeded the cells into 96-well, flat-bottom microtiter plates with 2 x lo5 cells/well of irradiated (40 Gy) feeder cells SUB024, an EpsteinBarr virus-transformed B-cell line derived from PBMCs of a patient with infectious mononucleosis.
Cell culture. We cultured the cells in RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% heat-inactivated fetal calf serum (Flow Laboratory, McLean, VA) in a humidified incubator with 5% CO, at 37°C. T-cell clones were cultured with 1 nmol/L IL-2 and irradiated feeder cells (SUB024) were added to the culture every 2 weeks.
MoAbs used in this study were anti-TacZ3 and 7G7/B624 (kindly provided by Dr David L. Nelson, National Cancer Institute, Bethesda, MD) as anti-IL-2R a chain, and 2R-BX and Mik-p3Z6 (kindly provided by Dr M. Tsudo, Unitika Hospital, Kyoto, Japan) as anti-IL-2R p chain. Anti-Tac and 2R-B compete for IL-2 binding to a and p chain, respectively. MoAbs 7G7iB6 and Mik-p3 recognize the IL-2R a and p chain, respectively, but they do not inhibit IL-2 binding to the receptor.
Cells were stained and flow cytometric analysis was performed as previously described.,' In brief, we incubated 3 x lo5 cells for 30 minutes at 4°C with fluorescein isothiocyanate (F1TC)-conjugated anti-Tac (12 pg/mL) and 2R-B (6 pg/mL) MoAbs in a final volume of 40 kL. There was a possibility that contaminated IL-2 in the culture supernatant bound to IL-2R a or We used recombinant human IL-3 (1 X lo8 U/mg) and rabbit antihuman IL-3 (both kindly provided by Dr K. Asano, Kirin Brewery, Maebashi, Japan). In earlier experiments, anti-IL-3 antibody (Ab) was found to neutralize the activity of 10 ng (10' U/mL of IL-3 when used at a 1/1,000 concentration of the serum.
The methods used have been described elsewhere.*' Briefly, we labeled IL-2 with N a 9 (Amersham Japan, Tokyo) by using Enzymobeads (Bio-Rad Laboratories, Richmond, CA) or chrolamine T (Nacalai Tesque, Kyoto, Japan). The specific activity of this IL-2 was 14,000 to 18,000 cpm/ng. The cloned T cells, cultured without IL-2 for 24 hours, washed, and cultured in fresh medium with or without prescreened concentrations of IL-3 for another 12 hours, were then washed thoroughly to perform the lXI-labeled IL-2 binding assay.
For this assay, washed cells were cultured withvarious concentrations of '2SI-labeled IL-2 at 4°C for 60 minutes with or without an excess amount of unlabeled IL-2 in the binding medium (RPMI 1640 with 25 mmol/L HEPES, 1 mg/mL of NaN,, and 10 mg/mL of bovine serum albumin [BSA] at pH 7.4). We centrifuged the labeled cells over the oil cushion (20% olive oil, 80% di-n-butyl phthalate), and measured both cell-bound and free radioactivities.
The specific binding was calculated by subtracting the nonspecific binding observed in the presence of a 250-fold excess of unlabeled IL-2. The number of binding sites and kd were calculated from Scatchard plots.
To detect the IL-2R a and p chain gene-specific sequences, we used the Sau3AI fragment of pKCR-Tac-2AZ8 and 2-kbp fragments encoding nucleotide positions 118 to 2,330 and 1,600 to 3,572 of the published sequence of IL-2R p chain? respectively (both kindly provided by Dr T. Honjo, Kyoto University, Kyoto, Japan). The probes of complementary deoxyribonucleic acid (cDNA) for p-actin was purchased from Nippon Gene (Tokyo, Japan). These probes were "P-labeled by the multiprime DNA labeling system (Amersham International, Buckinghamshire, England) or by a nick translation kit (Amersham).
We isolated the total RNA from cells and performed Northern blot analysis as previously described?' In brief, we washed cells in phosphate-buffered saline solution and extracted total RNA by guanidine isothiocyanate solubilization followed by centrifugation through cesium chloride. Isolated RNA (20 pg) from each sample was applied to 1% agarose gel, electrophoresed, and transferred to a nylon filter. The filter was hybridized with labeled probes for IL-2R a chain, p chain, and p-actin, sequentially, and exposed to an x-ray film at -70°C with an intensifying screen.
As previously described: 5 x lo6 cells were lysed by adding 0.5% Nonidet P-40 in the presence of 10 mmol/L Vanadyl ribonucleoside complex (Bethesda Research Laboratories Inc, Bethesda, MD). After pelleting the nuclei, we incubated the supernatant with 7.4% formaldehyde and 6x standard saline citrate (0.15 mol/L NaCl, 0.015 mol/L trisodium citrate) at 60°C for 15 minutes. The samples, serially diluted with 15X standard saline citrate, were applied with suction to a 4-mm diameter spot on nylon filters starting with cytoplasmic extracts
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derived from 1 x lo6 cells with a twofold serial dilution. After prehybridization, we hybridized the filters with labeled probes for IL-2R a chain, p chain, and p-actin.
We estimated internalization of IL-2 receptor p chain by T-cell clones as internalized Mik-p3 MoAb (described else~here"~'~) with some modifications, using radiolabeled Mik-p3 MoAb. Mik-p3 MoAb was labeled with NaIZ5I using Enzymobeads with specific activity of 7,500 cpm/ng. Cells (3 x 10') were incubated with a half-saturating concentration (700 ng/mL) of '%labeled Mik-p3 MoAb with or without a 250-fold excess of unlabeled Mik-p3 MoAb for 30 minutes at 4°C in RPMI 1640 with 25 mmol/L HEPES and 10 mg/mL of BSA at pH 7.4. Then we transferred the cells to a 37°C water bath with or without 500 U/mL of IL-3. Chloroquine (100 pmol/L; Sigma Chemical, St Louis, MO) added to each culture prevented degradation of internalized '2SI-labeled Mik-p3 MoAb. After the indicated times, we removed two aliquots of cells and passed one of them through an oil cushion. The other aliquot was resuspended in acidic buffer (0.2 mol/L glycine, 0.14 mol/L NaCl, and 10 mg/mL of BSA at pH 3.0) with gentle pipetting for 30 seconds at 23°C and centrifuged over an oil cushion. The radioactivity of the cell pellet was counted to determine the total cellassociated and internalized (acid-resistant) Mik-p3 MoAb, respectively. We counted all samples in duplicate, and calculated specific binding by subtracting nonspecific counts determined by the radioactivity of the cells incubated with an excess amount of unlabeled Mik-p3 MoAb. In some experiments, cells were preincubated with or without 500 U/mL of IL-3 for 3 hours at 37°C before incubation with "%labeled Mik-p3 MoAb at 4°C.
Short-term cell proliferation was determined by measuring 'H-thymidine (,H-TdR) incorporation into cells, as previously described." That is, cells (2 x 105/well) were cultured in 96-well microtiter plates in the presence of the indicated concentrations of IL-2 plus IL-3 at 37°C for the required time. For the last 6 hours, we added 0.5 pCi/well of 'H-TdR to each well and then harvested the cells on a fiberglass filter. A liquid scintillator measured incorporated radioactivity.
Determination of the intemalized IL-2R p chain.
Cellproliferation assay.

RESULTS
The established T-cell clones P607 and 1C2 were both CD4+ cells (their clonality was shown by the analysis of rearrangement patterns of the genes encoding the p chain of the T-cell receptor; data not shown). Expression of IL-2R a and p chain on the cloned cells, determined by the reactivity with anti-Tac and 2R-B MoAbs, depended on the duration of culture from the last stimulation by SUB024 cells. We studied the time course of the IL-2R expression in the clones after the addition of irradiated SUB024. IL-2R a chain was increased by the addition of SUB024 and then was followed by a gradual reduction; p chain showed a slight change throughout the culture (data not shown). Because both a and p chain showed a stable expression from 2 weeks after the last addition of SUB024, all subsequent experiments were performed in the third week.
In six preliminary experiments, we compared the mode of IL-2R expression at different time schedule from the initiation of IL-2 starving. Expression of IL-2R a chain decreased gradually and that of IL-2R p chain increased rapidly during the initial 24 hours and both then reached a plateau. We confirmed that the viability of these cells cultured with medium alone could be retained for a period
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For personal use only. We used flow cytometric analysis to examine the effect of IL-3 on the expression of IL-2R a and p chain. In T-cell clones P607 and 1C2, the surface expression of IL-2R p chain determined by reactivity with 2R-B MoAb decreased with the addition of IL-3 (50% ? 6% [n = 61 and 32% ? 5% [n = lo], respectively) (Fig l) , whereas IL-3 had little effect on the expression of IL-2R a chain determined by reactivity with anti-Tac or 7G7/B6 MoAbs. IL-3 also reduced the reactivity of the T-cell clones with biotinylated Mik-p3 MoAb, which recognized the non-IL-2 binding epitope on the IL-2R p chain.
Using 'ZSI-labeled IL-2 binding assay and Scatchard plot analysis, we next examined the effect of IL-3 on the expression of high-and low-affinity IL-2R on P607 and 1C2. The P607 cells cultured in the medium alone expressed 3,800 sites/cell of high-affinity IL-2R (kd 11 pmol/L) and 39,000 sites/cell of low-affinity IL-2R (kd 11 nmol/L), as shown in Fig 2. By contrast, when cultured with 100 U/mL of IL-3 for 12 hours at 37"C, the P607 cells expressed a decreased number of high-affinity IL-2R sitedcell (2,500;
Effect of IL-3 on the expression of IL-2R.
kd 12 pmol/L), but the number of low-affinity IL-2R sites/cell(38,000; kd 10 nmol/L) remained unchanged.
We conducted four independent '"I-labeled IL-2 binding assays in 1C2 cells and have summarized the results in Table 1 . In cells treated with IL-3 for 12 hours, the number of high-affinity IL-2R sites decreased, but the affinity remained similar in both treated and untreated cells. However, no changes were detected either in the number or in the affinity of low-affinity IL-2R sites. The degree of reduction in binding sites of the high-affinity IL-2R calculated by Scatchard plot analysis was 28% to 44% in 1C2 cells pretreated with IL-3. The results correlated well with the reduced AMFI of p chain expression detected by flow cytometric analysis.
When cells were pretreated with 100 U/mL of IL-3 at 4°C for 30 minutes in the binding medium containing 1 mg/mL of NaN, and an 'Z51-labeled IL-2 binding assay was performed in the presence of IL-3, the number and affinity of both high-and low-affinity IL-2R sites on 1C2 cells were not affected (data not shown).
The p chain gradually decreased as the concentration of IL-3 was increased, reaching a minimum level at an IL-3 concentration of 256 U/mL and followed by a plateau (Fig  3) . In contrast, expression of IL-2R OL chain was very slightly affected by the addition of up to 4,096 U/mL of IL-3.
Kinetics of the downregulation of IL-2R p chain expression by IL-3. We analyzed the kinetics of the IL-3-induced reduction for the first 3 hours after IL-3 was added, but this was followed by an abrupt and progressive decrease at 3 hours, reaching a minimum plateau by 8 hours (Fig 4) . 
Direct effect of IL-3 on the reduction of IL-2R /3 chain.
Adding rabbit antihuman IL-3 antisera but not normal rabbit serum to the culture resulted in almost complete inhibition of IL-2R p chain downregulation (Fig 5) , and this
indicates that the inhibition is the effect of IL-3 itself. Furthermore, we tested IL-2 activity in the culture supernatant by the proliferation of the IL-2-dependent T-cell line Kit 225" in which growth was not affected by the addition of IL-3. The analysis disclosed no detectable amount of IL-2 ( < 2 pmol/L; data not shown). Fig 6) . In a further analysis with cytoplasmic dot hybridization technique, addition of IL-3 induced a twofold increase in the mRNA for IL-2R p chain at 3 hours (Fig 7A, lane h) . We detected an increase in the expression of mRNA for p-actin by IL-3, but not to the degree observed for IL-2R p chain (Fig 7B, lane h) . No difference in the expression of mRNA for the IL-2R p chain between cells cultured with medium alone and with IL-3 was disclosed at 6, 9, and 12 hours. IL-3 did not affect the mRNA concentration for IL-2R (Y chain (data not shown). closed that internalization was not affected for the first 120 minutes, but was accelerated beginning at 150 minutes when incubated with IL-3 ( Fig 8A) . When 1C2 cells were precultured with IL-3 at 37°C for 3 hours before incubation with "51-labelcd Mik-P3 MoAb at 4"C, internalization of Mik-f33 MoAb was accelerated from the beginning of the culture at 37°C (Fig 8B) .
Efect of IL-3 on the internalization of
Effect of IL-3 on the IL-2-mediated proliferation of T-cell clones. When we added only IL-3, we saw dose-dependent stimulation of the proliferation of both P607 and IC2 cells, evaluated by the incorporation of 'H-TdR. At an IL-3 concentration of 100 U/mL, the count increased from 5,948 2 888 to 12,152 ? 636 in P607 and from 2,577 t 487 to 7,029 2 672 in IC2 (Fig 9) . The addition of an excess amount of anti-Tac MoAb (100 kg/mL) inhibited the IL-Zmediated but not IL-3-mediated cell proliferation, suggesting that the cell proliferation induced by IL-3 was not due to the IL-2 secreted from T-cell clones on stimulation with IL-3. However, a significant decrease in the magnitude of IL-2-induced cell proliferation was seen after 100 U/mL of IL-3 was added (Fig 9) . This effect was dose-dependent; we saw IL-Zinduced cell proliferation less inhibited at a Concentration of 1 0 U/mL IL-3, and this became marginal at 1 U/mL. respectively. The binding assay with 'ZSI-labeled IL-2 disclosed that IL-3 induced a decrease in the number of high-affinity IL-2 receptors. The results are compatible with the reduction of p chain surface expression proved by flow cytometric analysis. However, on the contrary, IL-3 showed no effect on the expression of IL-2R cy chain in the simultaneous analysis using these methods. In murine, IL-3 has been reported to enhance the expression of cy chain in the hematopoietic cell lines FDC-P1 and DX-1, but it has no obvious effect on T cells.36
With the use of lZ5I-IL-2 binding assay, we showed that IL-3 induces a decrease in the number of high-affinity IL-2 receptors in human T cells. This effect was not observed when 100 U/mL of IL-3 was added to the culture at 4°C in the presence of NaN, 30 minutes before the assay was performed, thereby refuting the suggestion that the receptor decrease was due to the competitive inhibition by IL-3 of 'Z51-labeled IL-2 binding to its receptor, as in the case of IL-3 and granulocyte-macrophage colony-stimulating facIn the T-cell clones used here, IL-2 also reduced the surface expression of IL-2R p chain within 1 hour (data not shown). However, the IL-3-mediated p chain downregulation does not seem to be an indirect effect of IL-2 produced by the cells stimulated with IL-3, as no detectable IL-2 was secreted in the culture medium. IL-3 also reduced the reactivity of the T-cell clones with biotinylated Mik-p3 MoAb, which recognized the non-IL-2 binding epitope on 
